Waddell C C, Taunton O D, Twomey J J
J Clin Invest. 1976 Oct;58(4):950-4. doi: 10.1172/JCI108548.
Plasma for patients with primary type IV or V hyperlipoproteinemia inhibited [3H]thymidine incorporation by cultured mononuclear leukocytes. This previously unreported abnormality affected mononuclear leukocytes from patients with type IV or V hyperlipoproteinemia and from normal subjects. Patient cells incorporated [3H]thymidine normally when washed and incubated in medium containing normal plasma. Both spontaneous incorporation and stimulated incorporation in response to various mitogens and antigens were inhibited. The inhibitory effect was identified with the chylomicron and very low density lipoprotein fractions isolated from plasma and was concentration-dependent. Lectin used to stimulate cultured cells and [3H]thymidine used to measure responses were not bound to the lipoproteins in appreciable amounts. [3H]-Thymidine incorporation correlated well with morphologic evidence of lymphoproliferation. The mechanism of the inhibitory effect of type IV or V hyperlipoproteinemic plasma upon the response tested was not identified by may be related to interaction between lipoproteins and the cell membranes. We suggest that these lipoproteins may also interfere with the function of other cells.
原发性IV型或V型高脂蛋白血症患者的血浆抑制培养的单核白细胞掺入[3H]胸腺嘧啶核苷。这种以前未报道过的异常情况影响了IV型或V型高脂蛋白血症患者以及正常受试者的单核白细胞。当在含有正常血浆的培养基中洗涤并孵育时,患者细胞正常掺入[3H]胸腺嘧啶核苷。自发掺入以及对各种有丝分裂原和抗原的刺激掺入均受到抑制。从血浆中分离出的乳糜微粒和极低密度脂蛋白部分具有这种抑制作用,且呈浓度依赖性。用于刺激培养细胞的凝集素和用于测量反应的[3H]胸腺嘧啶核苷与脂蛋白的结合量并不显著。[3H]胸腺嘧啶核苷掺入与淋巴细胞增殖的形态学证据密切相关。IV型或V型高脂蛋白血症血浆对所测试反应的抑制机制尚未明确,可能与脂蛋白和细胞膜之间的相互作用有关。我们认为这些脂蛋白也可能干扰其他细胞的功能。